A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)

Clinical trial NCT07296445 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07296445
Sponsor: SDK Therapeutics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Promyelocytic Leukemia (APL)Acute Promyelocytic Leukaemia Acute Promyelocytic Leukemia With PML-RARA Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA APL Acute Promyelocytic Leukemia Leukaemia Leukemia Acute Promyelocytic Leukemia (APL)Leukemia, Acute

Start date: 2026-01-01
Primary completion: 2027-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.